Monday, 30 July 2018

RedHill BioPharma has positive results from Crohn's disease trial

Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with its treatment for Crohn's disease called RHB-104.


No comments:

Post a Comment